From: In vitro blood cell responsiveness to IFN-α predicts clinical response independently of IL28B in hepatitis C virus genotype 1 infected patients
Therapeutic outcome
Genotype 1
Genotype 3
P value§
RVR (%)
8 (42)
13 (57)
0.54
EVR (%)
15 (83)
20 (90)
0.64
EOT (%)
13 (72)
19 (86)
0.68
SVR (%)
10 (62.5)
13 (65)
0.74
Relapse (%)
3 (23)
6 (33)
1